HFS
KYMR icon

Hughes Financial Services’s Kymera Therapeutics KYMR Stock Holding History

Hughes Financial Services’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344 Buy
3
+1
+50% +$86 ﹤0.01% 1170
2026
Q1 		$167 Buy
+2
New +$158 ﹤0.01% 1141

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Hughes Financial Services's KYMR Position: Q2 2026 in Review

Hughes Financial Services increased its Kymera Therapeutics (KYMR) stake by 50% in Q2 2026, buying an estimated $86 and bringing the position to 3 shares worth $344. The position accounts for ﹤0.01% of the portfolio, ranked #1170.

Hughes Financial Services first reported a position in KYMR in Q1 2026 and has held it in 2 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Hughes Financial Services held 3 shares of Kymera Therapeutics worth $344 as of Q2 2026.
  • Hughes Financial Services bought 1 Kymera Therapeutics share in Q2 2026, an estimated $86.
  • Kymera Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1170 holding.
  • Hughes Financial Services first reported a position in Kymera Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.